RCKT in the 13F filings
Rocket Pharmaceuticals Inc · CUSIP 77313F106
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 2 Sep 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 24
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 2 listed it in both
- Shares listed
- 20,854,969
- combined, among listed positions
- Reported value
- $71m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 13 buyers (opened or added shares) and 11 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -985,842.
Managers listing RCKT in Q2 2026
24 of 24 holders
Largest increases and reductions, by shares
Increases
- Marshall Wace LLPexisting position · 4,029,262 shares now+990,547
- Millennium Management LLCexisting position · 4,000,344 shares now+882,220
- Maverick Capital Ltdexisting position · 3,923,963 shares now+356,591
- AQR Capital Management LLCexisting position · 3,386,162 shares now+316,232
- Renaissance Technologies LLCexisting position · 792,974 shares now+155,800
Reductions
- D. E. Shaw & Co.existing position · 950,552 shares now-1,219,073
- Two Sigma Investments LPexisting position · 315,761 shares now-781,862
- T. Rowe Price Associates Incexisting position · 187,415 shares now-672,459
- Susquehanna International Group LLPexisting position · 39,335 shares now-346,304
- Point72 Asset Management LPexisting position · 670,527 shares now-341,599
New positions and exits
New (4)
Exited (3)
- Jane Street Group LLCwas $2.2m
- Verition Fund Management LLCwas $40k
- Quantbot Technologies LPwas $1k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2018 | 2 | $1.3m | n.a. | n.a. |
| Q4 2018 | 1 | $1.5m | n.a. | n.a. |
| Q2 2019 | 1 | $2.7m | n.a. | n.a. |
| Q4 2019 | 1 | $8.1m | n.a. | n.a. |
| Q4 2020 | 3 | $228m | n.a. | n.a. |
| Q1 2021 | 2 | $178m | n.a. | n.a. |
| Q2 2021 | 3 | $210m | n.a. | n.a. |
| Q3 2021 | 1 | $50m | n.a. | n.a. |
| Q4 2021 | 1 | $41m | n.a. | n.a. |
| Q1 2022 | 3 | $37m | n.a. | n.a. |
| Q2 2022 | 2 | $36m | n.a. | n.a. |
| Q3 2022 | 2 | $42m | n.a. | n.a. |
| Q4 2022 | 2 | $71m | n.a. | n.a. |
| Q1 2023 | 3 | $86m | n.a. | n.a. |
| Q2 2023 | 1 | $87m | n.a. | n.a. |
| Q3 2023 | 2 | $280m | n.a. | n.a. |
| Q4 2023 | 3 | $395m | 2 | 1 |
| Q1 2024 | 3 | $422m | 2 | 1 |
| Q2 2024 | 4 | $357m | 3 | 1 |
| Q3 2024 | 4 | $330m | 3 | 1 |
| Q4 2024 | 5 | $320m | 5 | 0 |
| Q1 2025 | 1 | $35m | 1 | 0 |
| Q2 2025 | 2 | $21m | 2 | 0 |
| Q3 2025 | 2 | $28m | 1 | 0 |
| Q4 2025 | 2 | $9.6m | 14 | 12 |
| Q1 2026 | 2 | $13m | 15 | 14 |
| Q2 2026 | 2 | $14m | 13 | 11 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
RCKT and LLY →RCKT and JNJ →RCKT and VRTX →Choose a stock to compare with RCKT →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own RCKT, latest filings →Back to the 13F Explorer →